Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.41 |
| ▸ | PARP1 | P09874 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30104202 | 1.00 | PDK2 (0.41) | PDK2PARP1KMT2AGAAMEN1 | |
| SCHEMBL30125362 | 0.94 | PDK2 (0.40) | PDK2PARP1KMT2AGAAMEN1 | |
| SCHEMBL165110 | 0.94 | PDK2 (0.40) | PDK2PARP1KMT2AGAAMEN1 | |
| SCHEMBL16301275 | 0.87 | PDK2 (0.38) | PDK2KMT2AGAAMEN1HPGD | |
| SCHEMBL13868700 | 0.87 | TUBB4A (0.40) | PDK2PGRAR | |
| SCHEMBL4572109 | 0.86 | PDK2 (0.34) | PDK2PARP1KMT2AGAAMEN1 | |
| SCHEMBL15247981 | 0.86 | PDK2 (0.34) | PDK2PARP1KMT2AGAAMEN1 | |
| SCHEMBL23572575 | 0.85 | ALDH1A1 (0.38) | PDK2KMT2AMEN1L3MBTL1ALDH1A1 | |
| SCHEMBL4568638 | 0.85 | PDK2 (0.34) | PDK2PARP1KMT2AGAAMEN1 | |
| SCHEMBL30104203 | 0.85 | ALDH1A1 (0.38) | PDK2KMT2AMEN1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3367143-B1 | POLARIZING PHOTOCHROMIC DEVICES AND METHODS OF MAKING THE SAME | TRANSITIONS OPTICAL INC (US) | 2023-01-11 | — | — | EP | disclosed |
| US-11518751-B2 | Photochromic indeno-fused naphthopyran compounds with reduced temperature dependence | TRANSITIONS OPTICAL, LTD. (IE) | 2022-12-06 | — | — | US | disclosed |
| EP-3802508-B1 | PHOTOCHROMIC INDENO-FUSED NAPHTHOPYRAN COMPOUNDS WITH REDUCED TEMPERATURE DEPENDENCE | TRANSITIONS OPTICAL LTD (IE) | 2022-10-19 | — | — | EP | disclosed |
| US-20210198226-A1 | Photochromic Indeno-Fused Naphthopyran Compounds With Reduced Temperature Dependence | TRANSITIONS OPTICAL, LTD. (IE) | 2021-07-01 | — | — | US | disclosed |
| CN-105199708-B | Photochromic compounds | 光学转变公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-1639058-B1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2020-10-21 | — | — | EP | disclosed |
| CN-105838349-B | photochromic compounds | 光学转变公司 | 2019-12-06 | — | — | CN | disclosed |
| EP-2370420-B9 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2019-11-13 | — | — | EP | disclosed |
| EP-2370420-B1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2019-05-22 | — | — | EP | disclosed |
| EP-2357217-B9 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-20070047055-A1 | Polarizing, photochromic devices and methods of making the same | TRANSITIONS OPTICAL LIMITED (IE) | 2007-03-01 | — | — | US | disclosed |
| US-20070047054-A1 | Polarizing, photochromic devices and methods of making the same | TRANSITIONS OPTICAL LIMITED (IE) | 2007-03-01 | — | — | US | disclosed |
| US-20070041073-A1 | Polarizing, photochromic devices and methods of making the same | TRANSITIONS OPTICAL LIMITED (IE) | 2007-02-22 | — | — | US | disclosed |
| US-20070041071-A1 | Polarizing, photochromic devices and methods of making the same | TRANSITIONS OPTICAL LIMITED (IE) | 2007-02-22 | — | — | US | disclosed |
| EP-1642160-A1 | POLARIZING PHOTOCHROMIC DEVICES AND METHODS OF MAKING THE SAME | TRANSITIONS OPTICAL, INC. (US) | 2006-04-05 | — | — | EP | disclosed |
| EP-1639058-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005005570-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| WO-2005006035-A1 | POLARIZING PHOTOCHROMIC DEVICES AND METHODS OF MAKING THE SAME | TRANSITIONS OPTICAL, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20050012998-A1 | Polarizing, photochromic devices and methods of making the same | TRANSITIONS OPTICAL LIMITED (IE) | 2005-01-20 | — | — | US | disclosed |
| US-20050004361-A1 | Thermally reversible; absorption ratio greater than 2.3 | TRANSITIONS OPTICAL LIMITED (IE) | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198226-A1 | Photochromic Indeno-Fused Naphthopyran Compounds With Reduced Temperature Dependence | NR2E3, NR0B2, NR2C2 | PDK2 745/4885PARP1 2662/4885KMT2A 1967/4885 |
| US-20050004361-A1 | Thermally reversible; absorption ratio greater than 2.3 | CCND1, CCND3, CCND2 | PDK2 501/4885PARP1 1854/4885KMT2A 1838/4885 |
| US-11518751-B2 | Photochromic indeno-fused naphthopyran compounds with reduced temperature dependence | NR2E3, NR0B2, NR2C2 | PDK2 745/4885PARP1 2662/4885KMT2A 1967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.